Categories
Lupin Limited — Updates, 22-05-2026: Press Release
22-05-2026 · 03:48 pm
Lupin secures China approval for Oseltamivir Phosphate Oral Suspension, marking its strategic debut in the massive Chinese pharmaceutical market. This significant entry expands Lupin's global presence through a partnership with Yabao Pharmaceuticals.
No comments yet. Be the first to comment!